Depression and poor adherence to lipid-lowering medications among patients with coronary artery disease

Journal of Psychosomatic Research

Volumn 69, Issue 2, 2010, Pages 175-177

  Ziegelstein, Roy C ^a   Howard, Brian ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Adherence; Coronary artery disease; Depression; Statins

Indexed keywords

CLOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

CARDIAC PATIENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; HEALTH BEHAVIOR; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MORTALITY; NOTE; PATIENT COMPLIANCE; PRESCRIPTION; SELF REPORT;

AGED; CORONARY ARTERY DISEASE; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RECURRENCE;

EID: 77954620361     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2010.04.012     Document Type: Note

References (27)

1. Clofibrate and niacin in coronary heart disease. JAMA 1975, 231:360-381. Coronary Drug Project Research Group.
2. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980, 303:1038-1041. Coronary Drug Project Research Group.
3. May HT, Sheng X, Catinella AP, Horne BD, Carlquist JF, Joy E Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression. J Psychosom Res 2010.
4. DiMatteo MR, Lepper HS, Croghan TW Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
5. Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med 2009, 169:260-268.
6. Rasmussen JN, Chong A, Alter DA Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007, 297:177-186.
7. Andersohn F, Willich SN The healthy adherer effect. Arch Intern Med 2009, 169:1635-1636.
8. Horwitz RI, Viscoli CM, Berkman L Treatment adherence and risk of death after a myocardial infarction. Lancet 1990, 336:542-545.
9. Irvine J, Baker B, Smith J, Jandciu S, Paquette M, Cairns J, et al. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosom Med 1999, 61:566-575.
10. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005, 366:2005-2011.
11. McDermott MM, Schmitt B, Wallner E Impact of medication nonadherence on coronary heart disease outcomes. Arch Intern Med 1997, 157:1921-1929.
12. Ziegelstein RC, Bush DE, Fauerbach JA Depression, adherence behavior, and coronary disease outcomes. Arch Intern Med 1998, 158:808-809.
13. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001, 87:819-822.
14. Gee M, Hasson NK, Hahn T, Ryono R Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm 2002, 8:453-458.
15. Parra D, Beckey NP, Raval HS, Schnacky KR, Calabrese V, Coakley RW, et al. Veterans integrated service network 8 pharmacy benefits management utilization committee. Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol. Am J Cardiol 2005, 95:1481-1483.
16. Skodova Z, Nagyova I, van Dijk JP, Sudzinova A, Vargova H, Studencan M, et al. Socioeconomic differences in psychosocial factors contributing to coronary heart disease: a review. J Clin Psychol Med Settings 2008, 15:204-213.
17. Bane C, Hughes CM, McElnay JC The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns 2006, 60:187-193.
18. Singh JA Accuracy of Veterans Affairs databases for diagnoses of chronic diseases. Prev Chronic Dis 2009, 6:A126.
19. Miller NH, Hill M, Kottke T, Ockene IS The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997, 95:1085-1090.
20. Fox R Compliance, adherence, concordance. Circulation 1998, 97:127.
21. Rieckmann N, Gerin W, Kronish IM, Burg MM, Chaplin WF, Kong G, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 2006, 48:2218-2222.
22. Glassman AH, Bigger JT, Gaffney M Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009, 66:1022-1029.
23. Kumar V, Encinosa W Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients. Psychiatr Q 2009, 80:131-141.
24. Dalessandro M, Conti CM, Gambi F, Falasca K, Doyle R, Conti P, et al. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. J Clin Psychopharmacol 2007, 27:58-61.
25. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005, 38:432-438.
26. Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 2008, 47:384-390.
27. Walkup J, Wei W, Sambamoorthi U, Crystal S Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q 2008, 79:43-53.